Funding from Venture Capital and Private Equity firms
Latest trademark applications
Additional industries in which the company operates
DBA WESTLAKE BIOPARTNERS, LLC DBA Westlake BioPartners Fund I, L.P. DBA Westlake BioPartners Fund II, L.P. DBA WESTLAKE BIOPARTNERS, LLC DBA Westlake BioPartners Opportunity Fund I, L.P.
Last updated:
Company Awards
VC / Private Equity
Brain Power (IP)
Company Profile & Annual Report for Westlake BioPartners Fund III
Note: Westlake BioPartners Fund III's revenues are gauged from an analysis of company filings.
Westlake BioPartners Fund III's Income Statement (based on Industry Averages)
Westlake BioPartners Fund III P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Westlake BioPartners Fund III has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
June 29, 2023
0
0%
$450 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Westlake BioPartners Fund III is developing and marketing.
Westlake BioPartners Fund III doesn't have any recent trademark applications, indicating Westlake BioPartners Fund III is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
WESTLAKE VILLAGE BIOPARTNERS Business advisory services
04/02/2018
See all trademarks and details in the Full Report.
Market Share of Westlake BioPartners Fund III's Largest Competitors
A competitive analysis shows these companies are in the same general field as Westlake BioPartners Fund III, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Westlake BioPartners Fund III.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Westlake BioPartners Fund III's Fastest Growing Competitors
These companies are in the same general field as Westlake BioPartners Fund III and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.